Capital City Trust CO Bristol Myers Squibb CO Transaction History

Capital City Trust CO

$397 Million
Q3 2024

A detailed history of Capital City Trust CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Capital City Trust CO holds 21,147 shares of BMY stock, worth $1.2 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

21,147

Previous 24,830 14.83%

Holding current value

$1.2 Million

Previous $1.03 Million 6.11%

% of portfolio

0.28%

Previous 0.28%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$39.66 - $51.75 $146,067 - $190,595	-3,683 Reduced 14.83%	21,147 $1.09 Million
Q2 2024 Aug 09, 2024	BUY	$40.25 - $52.99 $3,260 - $4,292	81 Added 0.33%	24,830 $1.03 Million
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $1,631 - $1,849	34 Added 0.14%	24,749 $1.34 Million
Q4 2023 Jan 19, 2024	SELL	$48.48 - $57.85 $59,775 - $71,329	-1,233 Reduced 4.75%	24,715 $1.27 Million
Q3 2023 Oct 12, 2023	SELL	$57.89 - $64.73 $109,238 - $122,145	-1,887 Reduced 6.78%	25,948 $1.51 Million
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $76,706 - $85,170	-1,204 Reduced 4.15%	27,835 $1.78 Million
Q1 2023 Apr 19, 2023	BUY	$65.71 - $74.53 $110,195 - $124,986	1,677 Added 6.13%	29,039 $2.01 Million
Q4 2022 Jan 27, 2023	SELL	$68.48 - $81.09 $47,593 - $56,357	-695 Reduced 2.48%	27,362 $0
Q3 2022 Oct 21, 2022	SELL	$0.13 - $76.84 $30 - $17,826	-232 Reduced 0.82%	28,057 $1.99 Million
Q2 2022 Jul 15, 2022	BUY	$72.62 - $79.98 $3,776 - $4,158	52 Added 0.18%	28,289 $2.18 Million
Q1 2022 Apr 20, 2022	SELL	$61.48 - $73.72 $2,889 - $3,464	-47 Reduced 0.17%	28,237 $2.06 Million
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $16,357 - $19,068	-305 Reduced 1.07%	28,284 $1.76 Million
Q3 2021 Oct 19, 2021	BUY	$59.17 - $69.31 $51,892 - $60,784	877 Added 3.16%	28,589 $1.69 Million
Q2 2021 Jul 23, 2021	SELL	$61.91 - $67.42 $25,073 - $27,305	-405 Reduced 1.44%	27,712 $1.85 Million
Q1 2021 May 05, 2021	BUY	$59.34 - $66.74 $4,925 - $5,539	83 Added 0.3%	28,117 $1.78 Million
Q4 2020 Jan 14, 2021	SELL	$57.74 - $65.43 $143,945 - $163,116	-2,493 Reduced 8.17%	28,034 $1.74 Million
Q3 2020 Oct 21, 2020	BUY	$57.43 - $63.64 $67,365 - $74,649	1,173 Added 4.0%	30,527 $1.84 Million
Q2 2020 Jul 15, 2020	BUY	$54.82 - $64.09 $53,613 - $62,680	978 Added 3.45%	29,354 $1.73 Million
Q1 2020 Apr 23, 2020	BUY	$46.4 - $67.43 $17,075 - $24,814	368 Added 1.31%	28,376 $1.58 Million
Q4 2019 Jan 15, 2020	BUY	$49.21 - $64.19 $96,008 - $125,234	1,951 Added 7.49%	28,008 $1.8 Million
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $13,301 - $15,770	311 Added 1.21%	26,057 $1.32 Million
Q2 2019 Aug 02, 2019	BUY	$44.62 - $49.34 $24,942 - $27,581	559 Added 2.22%	25,746 $1.17 Million
Q1 2019 Apr 19, 2019	SELL	$45.12 - $53.8 $16,874 - $20,121	-374 Reduced 1.46%	25,187 $1.2 Million
Q4 2018 Jan 15, 2019	BUY	$48.76 - $63.23 $8,971 - $11,634	184 Added 0.73%	25,561 $1.33 Million
Q3 2018 Oct 18, 2018	SELL	$55.19 - $62.25 $50,333 - $56,772	-912 Reduced 3.47%	25,377 $1.58 Million
Q2 2018 Jul 20, 2018	BUY	$50.53 - $62.98 $14,350 - $17,886	284 Added 1.09%	26,289 $1.46 Million
Q1 2018 Apr 13, 2018	SELL	$59.92 - $68.98 $32,296 - $37,180	-539 Reduced 2.03%	26,005 $1.65 Million
Q4 2017 Jan 12, 2018	SELL	$59.94 - $65.35 $3,296 - $3,594	-55 Reduced 0.21%	26,544 $1.63 Million
Q4 2017 Jan 10, 2018	BUY	$59.94 - $65.35 $44,895 - $48,947	749 Added 2.9%	26,599 $1.7 Million
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $1.43 Million - $1.65 Million	25,850	25,850 $1.44 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $121B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital City Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Capital City Trust CO with notifications on news.

Account

Capital City Trust CO Bristol Myers Squibb CO Transaction History